| Education notes
SMU receives $5 million gift: Dallas business leader Edwin L. Cox has donated $5 million to support merit-based undergraduate scholarships in the school that bears his name – the Edwin L. Cox School of Business at Southern Methodist University. The gift will serve as a challenge grant to stimulate additional contributions toward a $10 million endowment fund for the Cox School's B.B.A. Scholars Program. .
Grosse Pointe hospital chiefs named
Beaumont Hospitals named three people Wednesday to run its newly purchased Grosse Pointe hospital. They are: Richard Swaine, senior vice president and hospital director. Swaine, of Livonia, is a 22-year Beaumont employee who most recently was vice president of finance for Beaumonts Royal Oak hospital. He also had been vice president, finance, at Beaumonts Troy hospital. He is a certified public accountant with a bachelors degree in business administration from Lawrence Institute of Technology and a masters degree in finance from Walsh College. .
GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the ...
PHILADELPHIA, Oct. 15 /PRNewswire-USNewswire/ -- GlaxoSmithKline (NYSE: GSK) announced today approval by the U.S. Food and Drug Administration (FDA) for oral HYCAMTIN(R) (topotecan) capsules for the treatment of relapsed small cell lung cancer (SCLC). Specifically, HYCAMTIN capsules are indicated for patients who had a complete or partial response to first-line chemotherapy and who are at least 45 days from the end of that treatment. HYCAMTIN capsules are the only oral single-agent chemotherapy approved for the treatment of SCLC after failure of first-line therapy. The product will be available in 2008. "The approval of HYCAMTIN capsules is particularly important for patients with relapsed small cell lung cancer as they now have an effective treatment option that has been shown to provide a survival benefit and can be conveniently taken at home," said Debasish Roychowdhury, M.D., Vice President, Global Clinical Development, Oncology Medicine Development Center, GSK.
Another year of the obtuse, odd and obscure
Throughout 2007, Telescope has brought you the sort of news that, quite frankly, doesn't quite fit into most people's definition of news. Take, for instance, this newspaper correction gleaned from the pages of the New York Times -- proving definitively that not only does that august journal publish all the jokes that are fit to print, but it strives to get them right, too: "Because of an editing error, an obituary on Sunday about Sid Raymond, a comic actor, rendered one of his jokes incorrectly. It was about a son who sends a prostitute to his widowed father, still a self-proclaimed ladies' man in his 90s. The prostitute tells the father that she is his birthday present and promises to give him 'super sex'... . The father replies, 'I'll take the soup.' " There is plenty more where that came from.
Belfast buried under 21 inches of snow
Coastal areas bore the brunt of the storms with 7,700 power outages reported in Rockland, Brunswick and Portland areas, according to Central Maine Power Co., which generates electricity for 80 percent of Maine's population.The first storm New Years Eve dropped 10 inches of snow on Belfast, according to Robert Richards, director of the Department of Public Works, who measures the accumulation at the public works garage and transfer station on Congress Street.The second storm on New Years Day landed an additional 11 inches of snow on the city, Richards said. .
Pills That Could Thrill in 2008
THE HEYDAY OF BLOCKBUSTER DRUG discoveries may be over, but drug makers still have breakthroughs in store in the next year, or so. To be sure, the drug industry is less productive than a decade ago. In 2007, drug companies launched 18 new drugs, the fewest since 1983, according to the market research firm IMS Health. And this year, regulators could approve 24 to 29 compounds, almost half the number approved in 1997. Still, there are bright spots. Experts helped Barron's Online identify five drugs expected to hit the market in 2008. All the drugs would improve treatment of serious medical conditions and eventually pay off. The list includes Merck & Co.'s cholesterol drug, Cordaptive and Cardiome Pharma's heart drug, Kynapid. Schering-Plough has the anesthesia medication sugammadex, and Roche Holding has Actemra for rheumatoid arthritis.
Living with acne
Drugstores offer a mind-boggling array of products and treatments that range from "The Power Pimple Peel" to the formidable sounding "Teminator 10," next to long-time standards such as Clearasil and Stridex. A stroll down most crowded malls will find a kiosk marketing Proactiv, the skin regimen touted by celebrities such as Jessica Simpson, Vanessa Williams and Sean "Diddy" Combs as an acne cure-all. "The over-the-counter stuff isn't necessarily bad for mild acne," Ganz said. "Look for topical creams, products with salycic acid or benzoyl peroxide; that's what's in Proactiv, by the way," she said. But you might want to see a dermatologist if the over- the-counter products don't work after two months, both Ganz and Lawley advise. "If they're using these things regularly, and the (skin) is not responding after two months, it should be worth it to go to a dermatologist and start prescription treatments," Lawley said.
|
